Market Tracker

01/26 7:56pm ET

Seattle Genetics Inc (NASDAQ:SGEN)

33.02
Data as of Jan 26
 +0.72 / +2.23%
Today’s Change
30.05
Today|||52-Week Range
55.99
+2.77%
Year-to-Date

Today’s Trading

Previous close32.30
Today’s open32.37
Day’s range32.07 - 33.14
Volume875,385
Average volume (3 months)1,367,609
Market cap$4.0B
Dividend yield--
Data as of 3:59pm ET, 01/26/2015

Growth & Valuation

Earnings growth (last year)-10.87%
Earnings growth (this year)-29.58%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+27.73%
P/E ratioNM
Price/Sales18.01
Price/Book17.21

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA+0.96+2.83%
ICPTIntercept Pharmaceut...+8.87+5.35%
RCPTReceptos Inc+5.64+5.12%
AKRXAkorn Inc-0.09-0.21%
Data as of 4:00pm ET, 01/26/2015

Financials

Next reporting dateFebruary 10, 2015
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$269.3M
Annual profit (last year)-$62.5M
Net profit margin-23.22%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts